Endothelial [tisu]
function [phsf]
Menopause [phsf]
effects [qlco]
Raloxifene [orch, phsu]
Administration [ocac]
postmenopausal [tmco]
Women [popg]
SEVERE DYSFUNCTION [fndg]
Endothelial [tisu]
premenopausal [tmco]
Women [popg]
Present [qnco]
Study [mnob]
Evaluated [ftcn]
Raloxifene [orch, phsu]
Administration [ocac]
Selective Estrogen Receptor Modulator [horm, phsu]
Endothelial [tisu]
Regulation [gora]
postmenopausal [tmco]
Women [popg]
DOUBLE BLIND [resa]
randomized [resa]
placebo [topp]
Trial [resa]
Health [idcn]
postmenopausal [tmco]
Women [popg]
treated [topp]
Raloxifene [orch, phsu]
mg/d [qnco]
placebo [topp]
months [tmco]
Evaluate [ftcn]
Raloxifene [orch, phsu]
treatment [ftcn]
Endothelial [tisu]
function [phsf]
Raloxifene [orch, phsu]
treated [topp]
Subject [grup]
N 30 [orch, phsu]
Raloxifene [orch, phsu]
Assessed [acty]
Intra-arterial infusion [topp]
N NOS [aapp, imft]
Arginine [aapp, bacs, phsu]
Raloxifene [orch, phsu]
Administration [ocac]
placebo [topp]
Decrease [qlco]
Plasma [bdsu]
Low Density Lipoprotein Cholesterol [bacs, strd]
P NOS [aapp, imft]
Triglyceride [bacs, lipd]
P NOS [aapp, imft]
thiobarbituric acid [orch]
Reactive [qlco]
Substance [sbst]
P NOS [aapp, imft]
Vascular Cell Adhesion Molecule-1 [aapp, imft]
P NOS [aapp, imft]
Intercellular adhesion molecule 1 [aapp, imft]
P NOS [aapp, imft]
E-Selectin [aapp, imft, rcpt]
P NOS [aapp, imft]
Levels [qlco]
Plasma [bdsu]
Trolox [orch, phsu]
Equivalent [qlco]
Antioxidant [phsu]
Capacity [qnco]
P NOS [aapp, imft]
Levels [qlco]
Raloxifene [orch, phsu]
treatment [ftcn]
Improvement [cnce]
Endothelial [tisu]
Dependent [qlco]
Vasodilatation [phsf]
Assessed [acty]
Brachial [spco]
Reactive [qlco]
Technique [ftcn]
Raloxifene [orch, phsu]
Administration [ocac]
IMPACT [gngm]
Endothelial [tisu]
Independent [idcn]
Vasodilatation [phsf]
Intra-arterial infusion [topp]
N NOS [aapp, imft]
Arginine [aapp, bacs, phsu]
inhibited [qlco]
Raloxifene [orch, phsu]
Endothelium [tisu]
mediated [socb]
Brachial [spco]
Arterial diameter [fndg]
Flow [npop]
Raloxifene [orch, phsu]
Administration [ocac]
Modulation [spco]
Endothelial [tisu]
Dependent [qlco]
Vasodilatation [phsf]
Likely [qlco]
reduction [npop]
risk factors [qnco]
Endothelial [tisu]
Damage [inpo]
